CA Stock MarketDetailed Quotes

ARCH Arch Biopartners Inc

Watchlist
  • 1.880
  • -0.020-1.05%
15min DelayMarket Closed Feb 24 16:00 ET
123.31MMarket Cap-30.32P/E (TTM)

About Arch Biopartners Inc Company

Arch Biopartners Inc is a late-stage clinical trial company focused on preventing acute kidney injury and organ damage caused by inflammation. The company is developing a platform of novel drugs that target the dipeptidase-1 (DPEP1) inflammation pathway, which is prevalent in the kidneys, lungs, and liver.

Company Profile

SymbolARCH
Company NameArch Biopartners Inc
Founded1983
MarketTSX
Fiscal Year Ends09-30
Address545 King Street West
CityToronto
CountryCAN
Zip CodeM5V 1M1
Phone+1 647 428-7031

Company Executives

  • Name
  • Position
  • Salary
  • Richard Muruve
  • Director, President and Chief Executive Officer
  • --
  • Andrew Bishop
  • Director and Chief Financial Officer
  • --
  • Dr. Daniel Muruve
  • Chief Science Officer
  • --
  • Claude Allary
  • Independent Director
  • --
  • Dr. Richard Rossman
  • Independent Director
  • --

Trending Stocks

Big Five Big Five

The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.

Unlock Now